Clinical Trials Browser

Phase 3 × Terminated × Afatinib × Clear all

NCT01345669 2017-12-07

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Phase 3 Terminated

617 enrolled 13 charts

Head and Neck Neoplasms